Agile Therapeutics
AGRX
AGRX was delisted on the 25th of March, 2024.
44 hedge funds and large institutions have $161M invested in Agile Therapeutics in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 5 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
43% more capital invested
Capital invested by funds: $113M → $161M (+$48.5M)
33% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 9
2% less funds holding
Funds holding: 45 → 44 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Senzar Asset Management
New York
|
+$3.05M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$1.55M |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$206K |
| 4 |
Invesco
Atlanta,
Georgia
|
+$190K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$190K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$4.25M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$952K |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$680K |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$285K |
| 5 |
SCM
Sio Capital Management
New York
|
-$47.5K |
AGRX Hedge Fund Activity: Q4 2015 in Review
44 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Agile Therapeutics (AGRX) for Q4 2015, worth a combined $161M — up 43% from $113M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of AGRX and 4 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 12 added.
The largest buyer was Senzar Asset Management, opening a new position worth an estimated $3.05M. The largest seller was RA Capital Management, exiting entirely with an estimated $4.25M sold.
- 44 institutional investors held Agile Therapeutics (AGRX) as of Q4 2015, down from 45 in Q3 2015.
- Funds reported $161M of Agile Therapeutics stock for Q4 2015, up 43% quarter-over-quarter.
- 4 funds opened new Agile Therapeutics positions in Q4 2015 and 5 closed out, a net change of -1 holder.
- The largest Agile Therapeutics buyer in Q4 2015 was Senzar Asset Management, an estimated $3.05M added.
- The largest Agile Therapeutics seller in Q4 2015 was RA Capital Management, an estimated $4.25M sold.
Based on aggregated 13F filings for Q4 2015.